The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
May 13th 2025
In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with epithelial ovarian cancer and high-risk prognostic factors.
Researchers Develop AI Model to Predict ICI Response in Advanced Melanoma
November 20th 2020Results of the artificial intelligence (AI) model were consistent no matter which immune checkpoint inhibitor (ICI) therapy patients received, suggesting that some biomarkers are not necessarily specific to the checkpoint target.
Read More
Risk of Death Differs for Elderly Patients With PAH Taking Endothelin Receptor Antagonists
November 20th 2020The mortality risk differs for the 3 endothelin receptor antagonists approved to treat pulmonary arterial hypertension (PAH) in elderly patients; however, a direct comparison in a controlled trial is still needed to confirm results.
Read More
Dr Clarence Moore Discusses the Importance of Chelation Therapy in Beta Thalassemia
November 19th 2020Clarence Moore, PharmD, BCPS, BCOP, assistant professor at Shenandoah University in Ashburn, Virginia, discussed the potential complications for patients with beta thalassemia associated with iron overload and the significance of chelation therapy.
Watch
Dr Peter McAllister Shares How COVID-19 Altered Patients' Migraine Symptoms
November 18th 2020While migraine was more manifest in some patients during the pandemic, others were able to adopt healthier habits, said Peter McAllister, MD, a neurologist, board certified headache specialist, and medical director of the New England Institute for Neurology and Headache.
Watch
Study Finds Genetic Overlap Between Sleep Disturbances, Migraine
November 17th 2020The genetic determinants of sleep and migraine partly overlap, suggesting sleep disturbances may causally influence migraine etiology and could be targets for migraine treatment, according to results of a Mendelian randomization study.
Read More
US Rheumatologists Reluctant to Switch to Biosimilars for Patients Doing Well on a Reference Product
November 16th 2020Although half of US rheumatologists have patients for which nonmedical switching has been suggested, only 35% were likely to switch patients with rheumatoid arthritis doing well on a reference product to a biosimilar.
Read More
Study Indicates ICS May Reduce New Cardiac Events in Patients With COPD
November 14th 2020A study looking at chronic obstructive pulmonary disease (COPD) and coronary heart disease found that inhaled corticosteroids (ICS) reduced future cardiac events in patients not known to have coronary heart disease.
Read More
Dr Rajiv Agarwal on the Future of Finerenone
November 13th 2020The FIDELIO-DKD program is perhaps just the beginning of seeing how finerenone can be used, said Rajiv Agarwal, MD, MS, FASN, a professor of medicine at Indiana University School of Medicine and a staff physician at the Veterans Affairs Medical Center in Indianapolis, Indiana.
Watch
Dr Nicola Hanania: Treatment of T2-High Asthma Is Constantly Evolving
November 11th 2020Treatment targets include several interleukins, immunoglobulin E, and alarmins, pointed out Nicola Hanania, MD, MS, pulmonary critical care physician and director, Airway Clinical Research Center, Baylor College of Medicine, Houston.
Watch